- Geron Appoints Vice President, Human Resources
- Phase Genomics Accelerates Microbiome Discovery and Antibiotic Resistance tracking with New ProxiMeta™ 8-Pack Including Bundled Analysis
- BeyondSpring Set to Join FTSE Russell 3000® Index
- BioSig Technologies Issues June 2019 Shareholder Letter
- Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729
- CytoDyn Submits 510(k) Pre-Submission Application to U.S. FDA for ProstaGene™ Prognostic Test
- Incysus Therapeutics Announces Publication of U.S. Patent for Drug Resistant Immunotherapy (DRI) Technology
- Myriad Genetics Receives Second Insurance Reimbursement Decision for its BRACAnalysis® Diagnostic System in Japan
- CytoDyn Announces Major Discovery for its Monotherapy Indication
- Polydex Pharmaceuticals Issues First Quarter Financial Results
